Skip to main content

Table 3 Subjective cognitive impairment and urinary tract symptoms among ketamine users and the adjusted odds ratios (AORs) between genders

From: Gender differences in subjective discontinuation symptoms associated with ketamine use

   Total Male Female AORsc P value 95% CI
Cognitive impairment Nil 23.9% 24.7% 20.2% reference - -
mild 53.6% 53.9% 52.3% 1.275 0.258 0.837-1.942
severe 22.4% 21.4% 27.5% 1.717 0.024* 1.075-2.741
Urinary tract symptoms Nil 49.5% 49.7% 48.4% reference - -
milda 45.8% 46.5% 41.9% 0.915 0.601 0.656-1.276
severeb 4.8% 3.8% 9.7% 2.719 0.001** 1.501-4.928
  1. aIndicating symptoms as urgency/frequency occasionally but not usually.
  2. bIndicating symptoms as both pelvic pain and urgency/frequency, or one of the symptoms achieved usually or always, or having received clinical help.
  3. cThe reference category is Nil group in cognitive impairment and urinary tract symptoms respectively, after adjusted age.
  4. P value: the risk of subjective cognitive impairment or urinary tract symptoms between genders 95% CI, 95% confidence intervals.
  5. *p < 0.05, ** p< 0.01.